
Subscribers to our Substack, The Contrarian Edge , received this commentary on Saturday, June 21.
Axcelis Technologies, Inc. designs, manufactures and services the ion implantation and other processing equipment used in the manufacture of semiconductor chips in the United States, Europe and Asia. The company is headquartered in Beverly, Massachusetts.
| Revenue (TTM) | $845.44M |
| Gross Profit (TTM) | $368.66M |
| EBITDA | $108.15M |
| Operating Margin | 4.00% |
| Return on Equity | 9.74% |
| Return on Assets | 4.52% |
| Revenue/Share (TTM) | $27.11 |
| Book Value | $33.99 |
| Price-to-Book | 4.25 |
| Price-to-Sales (TTM) | 4.78 |
| EV/Revenue | 4.869 |
| EV/EBITDA | 29.65 |
| Quarterly Earnings Growth (YoY) | -65.90% |
| Quarterly Revenue Growth (YoY) | 3.30% |
| Shares Outstanding | $30.73M |
| Float | $30.53M |
| % Insiders | 0.68% |
| % Institutions | 109.86% |
Volatility is currently expanding

Subscribers to our Substack, The Contrarian Edge , received this commentary on Saturday, June 21.

Axcelis Technologies (ACLS) closed at $176.85 in the latest trading session, marking a -7.7% move from the prior day.

Investors need to pay close attention to ACLS stock based on the movements in the options market lately.

From a technical perspective, Axcelis Technologies (ACLS) is looking like an interesting pick, as it just reached a key level of support. ACLS recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

BEVERLY, Mass., May 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The J.P.

Axcelis Technologies, Inc. (ACLS) Q1 2026 Earnings Call Transcript

The latest trading day saw Axcelis Technologies (ACLS) settling at $143.13, representing a +2.34% change from its previous close.

BEVERLY, Mass., April 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter of 2026 after market close on Thursday, May 7, 2026.

ACLS' $4.4B all-stock deal for VECO could broaden its tool lineup - if integration and China approval do not slow a near-term close.